BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Daiichi Pharmaceutical Co., Ltd. 

Japanese Headquarters
14-10 Nihonbashi 3-chome, Chuo-ku
Tokyo    103-8234  Japan
Phone: 03-3273-7101 Fax: 03-3281-8427


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Guilford Pharmaceuticals Inc.  Exclusive marketing, sales, and distribution rights to DOPASCAN ® Injection for Japan, Korea, and Taiwan.

Essential Therapeutics, Inc.   A 3 year collaboration entered into November 1995. The focus is on compounds that would overcome the efflux pump mechanism of bacterial resistance, to be used in combination with antibiotics targeting pseudomonas.





 Company News
AstraZeneca PLC (AZN) And Daiichi Pharmaceutical Co., Ltd. Sign $100M Nexium Deal 10/29/2010 7:43:44 AM    More...
Daiichi Pharmaceutical Co., Ltd. Names Dr. Jay Feingold Vice President, Medical Affairs Bolsters Company's Expertise in Areas of Oncology and Hematology 2/11/2010 10:50:04 AM    More...
Daiichi Pharmaceutical Co., Ltd. Profit Forecast Disappoints, Shares Dive 5/12/2009 7:40:26 AM    More...
Eli Lilly and Company (LLY) Release: Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use (CHMP) 12/19/2008 10:45:30 AM    More...
Ranbaxy Laboratories Says Daiichi Pharmaceutical Co., Ltd. Deal on Track, Shares Rise 7/16/2008 6:41:01 AM    More...
Daiichi Sankyo, Inc. Grants Priority Review for Daiichi Pharmaceutical Co., Ltd., Daiichi Pharmaceutical Co., Ltd. Drug, Prasugrel Investigational Antiplatelet Agent 2/22/2008 6:31:58 AM    More...
Daiichi Pharmaceutical Co., Ltd. Receives Import Approval For Ultrasound Contrast Medium Sonazoid 10/26/2006 6:31:53 PM    More...
Daiichi Pharmaceutical Co., Ltd. Selects MediData Solutions For Cost-Effective, Multilingual Clinical Trials 10/24/2006 11:24:52 AM    More...
Daiichi Pharmaceutical Korea To Become Wholly Owned Subsidiary Of Daiichi Pharmaceutical Co., Ltd. 10/10/2006 9:45:17 AM    More...
YM BioSciences (YM.TO) Licenses Monoclonal Antibody, Nimotuzumab, To Daiichi Pharmaceutical (JPN) For Japan; CIMYM BioSciences Inc. To Receive Up-Front Payment Of $14.5 Million 7/31/2006 10:53:12 AM    More...
12345

//-->